Marta Ferrán

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 125 citations · Full text

Medicine, Dermatology, Pharmacotherapy +9

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

Eva Vilarrasa, Pedro Herranz, L. Puig et al. · British Journal of Dermatology · 2012 · 99 citations

Medicine, Dermatology, Pharmacotherapy +14

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 98 citations

Pharmacy, Dermatology, Pharmacotherapy +17

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

J.M. Carrascosa, M. Vilavella, I. García‐Doval et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 77 citations

Medicine, Dermatology, Pharmacotherapy +14

Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

J. Notario, Gustavo Deza, Eva Vilarrasa et al. · Journal of Dermatological Treatment · 2018 · 74 citations

Medicine, Dermatology, Pharmacotherapy +13